Pictured: Ross Levine
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, December 9, 2013

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
In the News
By Christina Pernambuco-Holsten, MA  |  Friday, December 6, 2013

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.

Pictured: Michael Foley
Announcement
By Memorial Sloan Kettering  |  Thursday, December 5, 2013

A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.

Pictured: Casper zebrafish
Snapshot
By Jennifer Bell, PhD  |  Tuesday, December 3, 2013

Physician and cell biologist Richard White has generated a transparent and stripeless strain of zebrafish to study how tumors develop the capacity to metastasize to new organs.

Pictured: Joan Massagué
Announcement
By Celia Gittelson, BA  |  Monday, November 25, 2013

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.

Pictured: Oliver Zivanovic, Garrett Nash & Dennis Chi
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, November 15, 2013

Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, November 13, 2013

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.

Pictured: Sarat Chandarlapaty
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Friday, November 8, 2013

Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.

Pictured: Stephen Long & Alexandria Miller
Profile
By Celia Gittelson, BA  |  Thursday, November 7, 2013

Stephen Long works to understand how proteins work by determining what they look like in three dimensions.

Pictured: Craig Thompson
Event
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 4, 2013

Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.

Pictured: Clifford Hudis
Video
By Memorial Sloan Kettering  |  Friday, November 1, 2013

Medical oncologist Clifford Hudis says advances in immunology and molecular biology are leading to remarkable successes in cancer treatment.

Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Announcement
By Jim Stallard, MA, Writer/Editor  |  Thursday, October 24, 2013

Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.

Pictured: Mark Robson
Q&A
By Jim Stallard, MA, Writer/Editor  |  Monday, October 21, 2013

As genome sequencing of tumors becomes more routine, it increases the odds that additional disease-related mutations may be discovered by accident, a development that raises profound issues.

Pictured: Emily Foley
Profile
By Maureen Salamon, BA, Freelance Writer  |  Friday, October 18, 2013

Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.

Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, October 15, 2013

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.

Center News

Stay Informed

Get the latest information about cancer care and research every month.